Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H18F3NO |
| Molecular Weight | 273.294 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N1CCOC(C1)C2=CC(=CC=C2)C(F)(F)F
InChI
InChIKey=FVYUQFQCEOZYHZ-UHFFFAOYSA-N
InChI=1S/C14H18F3NO/c1-10(2)18-6-7-19-13(9-18)11-4-3-5-12(8-11)14(15,16)17/h3-5,8,10,13H,6-7,9H2,1-2H3
| Molecular Formula | C14H18F3NO |
| Molecular Weight | 273.294 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Oxaflozane is non-tricyclic antidepressant with serotoninergic action. In animals, oxaflozane has anti-cataleptic and anti-aggressive action with weak potentiation of stereotypes provoked by amphetamine. Oxaflozane was developed by Solvay Pharma and marketed in France under tradename Conflictan. The drug was discontinued in 2004.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:00:31 GMT 2023
by
admin
on
Fri Dec 15 19:00:31 GMT 2023
|
| Record UNII |
V4WLW77V5Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
N06AX10
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
||
|
WHO-VATC |
QN06AX10
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
26629-87-8
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
3044
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
m861
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
C75175
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
2007
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106996
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
C005357
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
SUB09486MIG
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
V4WLW77V5Q
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
247-855-8
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
100000083559
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
DB13457
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
432824
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY | |||
|
DTXSID50865308
Created by
admin on Fri Dec 15 19:00:31 GMT 2023 , Edited by admin on Fri Dec 15 19:00:31 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
